Clinical Trial Update: The SELEQT-HF (SELEnium and CoQ10 NuTrition for Heart Failure) Study Will Evaluate the Effect of Adding Selenium/and coQ10 on Top of Standard HF Therapy in Patients With HF and Will do so Using a Pragmatic, Registry Based Randomized Controlled Trial in the Netherlands. [Phase 3]

View source ↗

Summary

A Phase 3 pragmatic registry-based randomized trial (SELEQT-HF) in the Netherlands will evaluate adding selenium and CoQ10 to standard heart failure therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Coenzyme Q10 (Coenzyme Q10)
• Selenium supplement (selenium)

Snippet

Sponsor: Netherlands Heart Institute | Conditions: Heart Failure | Phase 3 | Status: NOT_YET_RECRUITING